{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:32:33Z","timestamp":1787023953776,"version":"build-2736575974"},"posted":{"date-parts":[[2026,4,8]]},"group-title":"In Review","reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,2]]},"abstract":"<title>Abstract<\/title>\n                <p>As psychedelic use increases and integrates with mainstream medicine, understanding the prevalence and nature of post-psychedelic adverse outcomes is critical. We investigated extended difficulties after psychedelic use via the Global Psychedelic Survey (GPS) 2025, which is a multilingual online survey of people who have used psychedelics. Data on the prevalence, characteristics, and associations of retrospectively reported extended difficulties was gained from N\u2009=\u20096,476 participants. The most common difficulties reported were existential struggle (36.6%), depression (34%), and derealization (29.4%). Existential struggle was rated as the most severe difficulty, but also the one contributing most to healing. Overall, 48.3% of participants reported one or more difficulties lasting 24 hours or more, and 9.9% experienced difficulties for over a year. Clinically relevant disruptive difficulties (defined as lasting at least a month that caused disruption to daily life) were reported by 8% of the sample and were associated with younger age at the time of survey and at first psychedelic use, lower income, lack of family support, lower emotional stability\/conscientiousness\/agreeableness, higher pre-existing anxiety\/depression, and using psychedelics to treat mental health conditions.  The results underscore the necessity for evidence-based education on the potential risks and benefits of psychedelics, robust safety guidelines in clinical psychedelic interventions, and additional services for those experiencing post-psychedelic extended difficulties.<\/p>","DOI":"10.21203\/rs.3.rs-9304959\/v1","type":"posted-content","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:42:56Z","timestamp":1775626976000},"source":"Crossref","is-referenced-by-count":2,"title":["Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample"],"prefix":"10.21203","author":[{"given":"C. Robinson","family":"Oliver","sequence":"first","affiliation":[{"name":"Regent's University London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Luke","sequence":"additional","affiliation":[{"name":"University of Greenwich"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Evans","sequence":"additional","affiliation":[{"name":"Challenging Psychedelic Experiences Project"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Aday","family":"Jacob","sequence":"additional","affiliation":[{"name":"University of Michigan\u2013Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Johnson","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lake","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kruger","sequence":"additional","affiliation":[{"name":"University at Buffalo, State University of New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Boehnke","family":"Kevin","sequence":"additional","affiliation":[{"name":"University of Michigan\u2013Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lucas","sequence":"additional","affiliation":[{"name":"University of Michigan\u2013Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1176\/appi.prcp.20240128","article-title":"On minimizing risk and harm in the use of psychedelics","volume":"7","author":"Evans J","year":"2025","unstructured":"Evans, J. et al. On minimizing risk and harm in the use of psychedelics. Psychiatr Res. Clin. Pract. 7, 4\u20138. https:\/\/doi.org\/10.1176\/appi.prcp.20240128 (2025).","journal-title":"Psychiatr Res. Clin. Pract."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/psymed.2024.0011","article-title":"Psychedelic therapist sexual misconduct and other adverse experiences among a sample of naturalistic psychedelic users","volume":"3","author":"Kruger DJ","year":"2025","unstructured":"Kruger, D. J. et al. Psychedelic therapist sexual misconduct and other adverse experiences among a sample of naturalistic psychedelic users. Psychedel Med. 3, 41\u201347. https:\/\/doi.org\/10.1089\/psymed.2024.0011 (2025).","journal-title":"Psychedel Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/02698811241265756","article-title":"A framework for assessment of adverse events occurring in psychedelic-assisted therapies","volume":"38","author":"Palitsky R","year":"2024","unstructured":"Palitsky, R. et al. A framework for assessment of adverse events occurring in psychedelic-assisted therapies. J. Psychopharmacol. 38, 690\u2013700. https:\/\/doi.org\/10.1177\/02698811241265756 (2024).","journal-title":"J. Psychopharmacol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"105105","DOI":"10.1016\/j.drugpo.2025.105105","article-title":"Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences","volume":"148","author":"Olofsson M","year":"2026","unstructured":"Olofsson, M. et al. Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences. Int. J. Drug Policy. 148, 105105. https:\/\/doi.org\/10.1016\/j.drugpo.2025.105105 (2026).","journal-title":"Int. J. Drug Policy"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2023.01.073","article-title":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","volume":"326","author":"Simonsson O","year":"2023","unstructured":"Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W. & Goldberg, S. B. Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. J. Affect. Disord. 326, 105\u2013110. https:\/\/doi.org\/10.1016\/j.jad.2023.01.073 (2023).","journal-title":"J. Affect. Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1287196","DOI":"10.3389\/fpsyt.2023.1287196","article-title":"Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample","volume":"14","author":"Kvam TM","year":"2023","unstructured":"Kvam, T. M. et al. Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample. Front. Psychiatry. 14, 1287196. https:\/\/doi.org\/10.3389\/fpsyt.2023.1287196 (2023).","journal-title":"Front. Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1556\/2054.2023.00291","article-title":"Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model","volume":"7","author":"Weiss B","year":"2023","unstructured":"Weiss, B., Sleep, C. E., Beller, N. M., Erritzoe, D. & Campbell, W. K. Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model. J. Psychedel Stud. 7, 200\u2013226. https:\/\/doi.org\/10.1556\/2054.2023.00291 (2023).","journal-title":"J. Psychedel Stud."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/02791072.2024.2401977","article-title":"The epidemiology of psychedelic use among United States military veterans","volume":"57","author":"Davis AK","year":"2025","unstructured":"Davis, A. K. et al. The epidemiology of psychedelic use among United States military veterans. J. Psychoact. Drugs. 57, 399\u2013412. https:\/\/doi.org\/10.1080\/02791072.2024.2401977 (2025).","journal-title":"J. Psychoact. Drugs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0293349","DOI":"10.1371\/journal.pone.0293349","article-title":"Extended difficulties following the use of psychedelic drugs: A mixed methods study","volume":"18","author":"Evans J","year":"2023","unstructured":"Evans, J. et al. Extended difficulties following the use of psychedelic drugs: A mixed methods study. PLOS ONE. 18, e0293349. https:\/\/doi.org\/10.1371\/journal.pone.0293349 (2023).","journal-title":"PLOS ONE"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1556\/2054.2024.00420","article-title":"An investigation into the varieties of extended difficulties following psychedelic drug use: Duration, severity and helpful coping strategies","volume":"9","author":"Robinson OC","year":"2025","unstructured":"Robinson, O. C., Evans, J., McAlpine, R. G., Argyri, E. K. & Luke, D. An investigation into the varieties of extended difficulties following psychedelic drug use: Duration, severity and helpful coping strategies. J. Psychedel Stud. 9, 117\u2013125. https:\/\/doi.org\/10.1556\/2054.2024.00420 (2025).","journal-title":"J. Psychedel Stud."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0000438","DOI":"10.1371\/journal.pgph.0000438","article-title":"Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey","volume":"2","author":"Bouso JC","year":"2022","unstructured":"Bouso, J. C. et al. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob Public. Health. 2, e0000438. https:\/\/doi.org\/10.1371\/journal.pgph.0000438 (2022).","journal-title":"PLOS Glob Public. Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro TM","year":"2016","unstructured":"Carbonaro, T. M. et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J. Psychopharmacol. 30, 1268\u20131278. https:\/\/doi.org\/10.1177\/0269881116662634 (2016).","journal-title":"J. Psychopharmacol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1199642","DOI":"10.3389\/fpsyt.2023.1199642","article-title":"Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: Results from a prospective, longitudinal survey","volume":"14","author":"Nayak SM","year":"2023","unstructured":"Nayak, S. M. et al. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: Results from a prospective, longitudinal survey. Front. Psychiatry. 14, 1199642. https:\/\/doi.org\/10.3389\/fpsyt.2023.1199642 (2023).","journal-title":"Front. Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/02698811231158245","article-title":"Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020","volume":"37","author":"Kopra EI","year":"2023","unstructured":"Kopra, E. I. et al. Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020. J. Psychopharmacol. 37, 733\u2013748. https:\/\/doi.org\/10.1177\/02698811231158245 (2023).","journal-title":"J. Psychopharmacol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.paid.2017.06.004","article-title":"Neuroticism is associated with challenging experiences with psilocybin mushrooms","volume":"117","author":"Barrett FS","year":"2017","unstructured":"Barrett, F. S., Johnson, M. W. & Griffiths, R. R. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Pers. Individ Differ. 117, 102\u2013107. https:\/\/doi.org\/10.1016\/j.paid.2017.06.004 (2017).","journal-title":"Pers. Individ Differ."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e30800","DOI":"10.1371\/journal.pone.0030800","article-title":"Prediction of psilocybin response in healthy volunteers","volume":"7","author":"Studerus E","year":"2012","unstructured":"Studerus, E., Gamma, A., Kometer, M. & Vollenweider, F. X. Prediction of psilocybin response in healthy volunteers. PLoS ONE. 7, e30800. https:\/\/doi.org\/10.1371\/journal.pone.0030800 (2012).","journal-title":"PLoS ONE"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","article-title":"Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects","volume":"4","author":"Aday JS","year":"2021","unstructured":"Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K. & Davoli, C. C. Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects. ACS Pharmacol. Transl Sci. 4, 424\u2013435. https:\/\/doi.org\/10.1021\/acsptsci.1c00014 (2021).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02791072.2024.2312980","article-title":"Effects of ayahuasca on gratitude and relationships with nature: a prospective, naturalistic study","volume":"57","author":"Aday JS","year":"2025","unstructured":"Aday, J. S. et al. Effects of ayahuasca on gratitude and relationships with nature: a prospective, naturalistic study. J. Psychoact. Drugs. 57, 171\u2013180. https:\/\/doi.org\/10.1080\/02791072.2024.2312980 (2025).","journal-title":"J. Psychoact. Drugs"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00224499.2025.2479197","article-title":"Perceived impact of psychedelics on sexual, gender, and intimate relationship dynamics: A mixed-methods investigation","volume":"62","author":"Kruger DJ","year":"2025","unstructured":"Kruger, D. J. et al. Perceived impact of psychedelics on sexual, gender, and intimate relationship dynamics: A mixed-methods investigation. J. Sex. Res. 62, 1\u201312. https:\/\/doi.org\/10.1080\/00224499.2025.2479197 (2025).","journal-title":"J. Sex. Res."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2026.01.007","article-title":"F. Blunted psychedelic drug effects in older adults","author":"Aday JS","year":"2026","unstructured":"Aday, J. S., Carhart-Harris, R. L. & Boehnke, K. F. Blunted psychedelic drug effects in older adults. Am. J. Geriatr. Psychiatry. http:\/\/doi.org\/10.1016\/j.jagp.2026.01.007 (2026).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects","volume":"218","author":"Griffiths RR","year":"2011","unstructured":"Griffiths, R. R. et al. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218, 649\u2013665. https:\/\/doi.org\/10.1007\/s00213-011-2358-5 (2011).","journal-title":"Psychopharmacology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"15998","DOI":"10.1038\/s41598-023-41145-x","article-title":"Case analysis of long-term negative psychological responses to psychedelics","volume":"13","author":"Bremler R","year":"2023","unstructured":"Bremler, R., Katati, N., Shergill, P., Erritzoe, D. & Carhart-Harris, R. L. Case analysis of long-term negative psychological responses to psychedelics. Sci. Rep. 13, 15998. https:\/\/doi.org\/10.1038\/s41598-023-41145-x (2023).","journal-title":"Sci. Rep."},{"key":"ref23","author":"Lake S","unstructured":"Lake, S. et al. The Global Psychedelic Survey 2025: Primary results from an international multilingual study of people who use psychedelics. Preprint at (under review)."},{"issue":"5","key":"ref24","doi-asserted-by":"publisher","first-page":"e0322501","DOI":"10.1371\/journal.pone.0322501","article-title":"Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences","volume":"20","author":"Argyri EK","year":"2025","unstructured":"Argyri, E. K. et al. Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences. PLOS ONE. 20 (5), e0322501. https:\/\/doi.org\/10.1371\/journal.pone.0322501 (2025).","journal-title":"PLOS ONE"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e71043","DOI":"10.1002\/brb3.71043","article-title":"The relationship between psychedelic use and positive adult development in emerging adulthood: An integrative review","volume":"15","author":"Payne J","year":"2025","unstructured":"Payne, J. et al. The relationship between psychedelic use and positive adult development in emerging adulthood: An integrative review. Brain Behav. 15, e71043. https:\/\/doi.org\/10.1002\/brb3.71043 (2025).","journal-title":"Brain Behav."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"119857","DOI":"10.1016\/j.jad.2025.119857","article-title":"Naturalistic psychedelic use and changes in depressive symptoms","volume":"390","author":"Simonsson O","year":"2025","unstructured":"Simonsson, O., Hendricks, P. S., Swords, C. M., Osika, W. & Goldberg, S. B. Naturalistic psychedelic use and changes in depressive symptoms. J. Affect. Disord. 390, 119857. https:\/\/doi.org\/10.1016\/j.jad.2025.119857 (2025).","journal-title":"J. Affect. Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01347-0","article-title":"Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: A qualitative analysis","author":"Argyri EK","year":"2025","unstructured":"Argyri, E. K. et al. Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: A qualitative analysis. Harm Reduct. J. https:\/\/doi.org\/10.1186\/s12954-025-01347-0 (2025).","journal-title":"Harm Reduct. J."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.52734\/HGSN7664","article-title":"Persistent altered states: Psychological treatment of psychedelic adverse effects","author":"Holm\u00f8y B","year":"2025","unstructured":"Holm\u00f8y, B. & Andersen, K. A. A. Persistent altered states: Psychological treatment of psychedelic adverse effects. Tidsskr Nor. Psykologforen. https:\/\/doi.org\/10.52734\/HGSN7664 (2025).","journal-title":"Tidsskr Nor. Psykologforen"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9304959\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9304959\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:42:59Z","timestamp":1775626979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9304959\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":28,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9304959\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,8]]},"subtype":"preprint"}}